disorders

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Rock and Roll Hall of Famer Dave Mason to Join Sophia’s Mission as their National Spokesperson

Source Node:
Time Stamp: October 25, 2022 5:31 PM - Modified On: October 25, 2022 - Published By:
Source Cluster:
Republished By Plato

Dave Mason Spokesperson Announcements will be aired on Sophia’s Mission’s NEWHD Media Stations New York— 10/19/2022 — Father Zachary Martin, Founder of Sophia’s Mission and longtime friend of Dave Mason is proud to announce that beginning in November, Dave is joining his cause to serve as National Spokesperson. Sophia’s Mission is a registered 501©3 that advocates and creates meaningful employment for people living on the Autistic Spectrum and with Disabilities (ASD). Sophia’s Mission’s NEWHD Media, is making it possible for people with ASD and Disabilities to enter the exciting profession